Related Experiment Video
Updated: May 11, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Treating gynecologic malignancies in elderly patients
Tamar Perri1, Tanya Katz, Jacob Korach
1*Department of Gynecologic Oncology, Sheba Medical Center, Tel Hashomer †Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
American Journal of Clinical Oncology
|May 22, 2013
Summary
Optimal treatment significantly improves survival for elderly gynecologic cancer patients. Full treatment should be prioritized regardless of age or comorbidities for better outcomes.
Area of Science:
- Oncology
- Geriatric Medicine
- Gynecologic Oncology
Background:
- Elderly patients with gynecologic malignancies often receive suboptimal treatment.
- Comorbidities and age are frequently cited reasons for undertreatment in this population.
Purpose of the Study:
- To compare the survival outcomes of elderly patients with gynecologic malignancies who received optimal versus suboptimal treatment.
- To evaluate the impact of treatment intensity on survival in this specific demographic.
Main Methods:
- Retrospective cohort study of 169 patients aged 79 and older with various gynecologic cancers.
- Patients were categorized into optimally treated (full standard care) and suboptimally treated (partial or no treatment) groups.
- Survival analysis utilized Kaplan-Meier curves and Cox proportional hazard models.
Main Results:
- Suboptimal treatment was associated with a 1.76-fold increased hazard ratio for death (P=0.004) compared to optimal treatment.
- For ovarian and endometrial cancers, suboptimal treatment significantly increased mortality risk (HR 2.15-2.30, P<0.02).
- Age and stage-adjusted analyses confirmed the survival benefit of optimal treatment, particularly for ovarian cancer.
Conclusions:
- Optimal treatment demonstrably improves survival for elderly patients with gynecologic malignancies.
- Treatment decisions should focus on delivering the best possible care, irrespective of patient age or comorbidities.
- This study supports the principle of providing standard-of-care treatment to elderly cancer patients.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...